{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:35:45Z","timestamp":1791408945853,"version":"4.3.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"25","license":[{"start":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T00:00:00Z","timestamp":1408924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T00:00:00Z","timestamp":1408924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,6,18]]},"DOI":"10.1038\/onc.2014.271","type":"journal-article","created":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T10:06:15Z","timestamp":1408961175000},"page":"3264-3272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death"],"prefix":"10.1038","volume":"34","author":[{"given":"C-S","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N-J","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A C","family":"Robeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kornbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,25]]},"reference":[{"key":"BFonc2014271_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFonc2014271_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nature11706","volume":"491","author":"A Schulze","year":"2012","unstructured":"Schulze A, Harris AL . How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012; 491: 364\u2013373.","journal-title":"Nature"},{"key":"BFonc2014271_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM . Cancer cell metabolism: Warburg and beyond. Cell 2008; 134: 703\u2013707.","journal-title":"Cell"},{"key":"BFonc2014271_CR4","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","volume":"279","author":"CR Santos","year":"2012","unstructured":"Santos CR, Schulze A . Lipid metabolism in cancer. FEBS J 2012; 279: 2610\u20132623.","journal-title":"FEBS J"},{"key":"BFonc2014271_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R . Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763\u2013777.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014271_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr . Cellular fatty acid metabolism and cancer. Cell Metab 2013; 18: 153\u2013161.","journal-title":"Cell Metab"},{"key":"BFonc2014271_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1158\/0008-5472.CAN-06-1794","volume":"67","author":"JL Little","year":"2007","unstructured":"Little JL, Wheeler FB, Fels DR, Koumenis C, Kridel SJ . Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res 2007; 67: 1262\u20131269.","journal-title":"Cancer Res"},{"key":"BFonc2014271_CR8","first-page":"1383","volume":"7","author":"PL Alo","year":"2000","unstructured":"Alo PL, Visca P, Framarino ML, Botti C, Monaco S, Sebastiani V et al. Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep 2000; 7: 1383\u20131388.","journal-title":"Oncol Rep"},{"key":"BFonc2014271_CR9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0046-8177(97)90177-5","volume":"28","author":"TS Gansler","year":"1997","unstructured":"Gansler TS, Hardman W 3rd, Hunt DA, Schaffel S, Hennigar RA . Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 1997; 28: 686\u2013692.","journal-title":"Hum Pathol"},{"key":"BFonc2014271_CR10","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011; 17: 1498\u20131503.","journal-title":"Nat Med"},{"key":"BFonc2014271_CR11","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1158\/0008-5472.CAN-06-3439","volume":"67","author":"W Zhou","year":"2007","unstructured":"Zhou W, Han WF, Landree LE, Thupari JN, Pinn ML, Bililign T et al. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells. Cancer Res 2007; 67: 2964\u20132971.","journal-title":"Cancer Res"},{"key":"BFonc2014271_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/bjc.2012.246","volume":"107","author":"MT Rahman","year":"2012","unstructured":"Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T et al. Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas. Br J Cancer 2012; 107: 300\u2013307.","journal-title":"Br J Cancer"},{"key":"BFonc2014271_CR13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1158\/1541-7786.MCR-10-0467","volume":"9","author":"K Tomek","year":"2011","unstructured":"Tomek K, Wagner R, Varga F, Singer CF, Karlic H, Grunt TW . Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Mol Cancer Res 2011; 9: 1767\u20131779.","journal-title":"Mol Cancer Res"},{"key":"BFonc2014271_CR14","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1101\/gad.12.9.1304","volume":"12","author":"L Bergeron","year":"1998","unstructured":"Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998; 12: 1304\u20131314.","journal-title":"Genes Dev"},{"key":"BFonc2014271_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mad.2006.11.030","volume":"128","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Padalecki SS, Chaudhuri AR, De Waal E, Goins BA, Grubbs B et al. Caspase-2 deficiency enhances aging-related traits in mice. Mech Ageing Dev 2007; 128: 213\u2013221.","journal-title":"Mech Ageing Dev"},{"key":"BFonc2014271_CR16","doi-asserted-by":"publisher","first-page":"19920","DOI":"10.1073\/pnas.1311947110","volume":"110","author":"J Puccini","year":"2013","unstructured":"Puccini J, Shalini S, Voss AK, Gatei M, Wilson CH, Hiwase DK et al. Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice. Proc Natl Acad Sci USA 2013; 110: 19920\u201319925.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014271_CR17","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1073\/pnas.0811928106","volume":"106","author":"LH Ho","year":"2009","unstructured":"Ho LH, Taylor R, Dorstyn L, Cakouros D, Bouillet P, Kumar S . A tumor suppressor function for caspase-2. Proc Natl Acad Sci USA 2009; 106: 5336\u20135341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014271_CR18","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/cdd.2013.38","volume":"20","author":"MJ Parsons","year":"2013","unstructured":"Parsons MJ, McCormick L, Janke L, Howard A, Bouchier-Hayes L, Green DR . Genetic deletion of caspase-2 accelerates MMTV\/c-neu-driven mammary carcinogenesis in mice. Cell Death Differ 2013; 20: 1174\u20131182.","journal-title":"Cell Death Differ"},{"key":"BFonc2014271_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.molcel.2011.07.028","volume":"43","author":"JL Andersen","year":"2011","unstructured":"Andersen JL, Thompson JW, Lindblom KR, Johnson ES, Yang CS, Lilley LR et al. A biotin switch-based proteomics approach identifies 14-3-3zeta as a target of Sirt1 in the metabolic regulation of caspase-2. Mol Cell 2011; 43: 834\u2013842.","journal-title":"Mol Cell"},{"key":"BFonc2014271_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cell.2005.07.032","volume":"123","author":"LK Nutt","year":"2005","unstructured":"Nutt LK, Margolis SS, Jensen M, Herman CE, Dunphy WG, Rathmell JC et al. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell 2005; 123: 89\u2013103.","journal-title":"Cell"},{"key":"BFonc2014271_CR21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1582-4934.2010.01037.x","volume":"14","author":"L Bouchier-Hayes","year":"2010","unstructured":"Bouchier-Hayes L . The role of caspase-2 in stress-induced apoptosis. J Cell Mol Med 2010; 14: 1212\u20131224.","journal-title":"J Cell Mol Med"},{"key":"BFonc2014271_CR22","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1038\/sj.onc.1211005","volume":"27","author":"LH Ho","year":"2008","unstructured":"Ho LH, Read SH, Dorstyn L, Lambrusco L, Kumar S . Caspase-2 is required for cell death induced by cytoskeletal disruption. Oncogene 2008; 27: 3393\u20133404.","journal-title":"Oncogene"},{"key":"BFonc2014271_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/sj.cdd.4402286","volume":"15","author":"H Vakifahmetoglu","year":"2008","unstructured":"Vakifahmetoglu H, Olsson M, Tamm C, Heidari N, Orrenius S, Zhivotovsky B . DNA damage induces two distinct modes of cell death in ovarian carcinomas. Cell Death Differ 2008; 15: 555\u2013566.","journal-title":"Cell Death Differ"},{"key":"BFonc2014271_CR24","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1091\/mbc.e05-12-1107","volume":"17","author":"C Bonzon","year":"2006","unstructured":"Bonzon C, Bouchier-Hayes L, Pagliari LJ, Green DR, Newmeyer DD . Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death. Mol Biol Cell 2006; 17: 2150\u20132157.","journal-title":"Mol Biol Cell"},{"key":"BFonc2014271_CR25","doi-asserted-by":"publisher","first-page":"13430","DOI":"10.1074\/jbc.M108029200","volume":"277","author":"Y Guo","year":"2002","unstructured":"Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES . Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002; 277: 13430\u201313437.","journal-title":"J Biol Chem"},{"key":"BFonc2014271_CR26","doi-asserted-by":"publisher","first-page":"40755","DOI":"10.1074\/jbc.M404726200","volume":"279","author":"CF Lin","year":"2004","unstructured":"Lin CF, Chen CL, Chang WT, Jan MS, Hsu LJ, Wu RH et al. Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramide and etoposide-induced apoptosis. J Biol Chem 2004; 279: 40755\u201340761.","journal-title":"J Biol Chem"},{"key":"BFonc2014271_CR27","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1038\/sj.emboj.7600827","volume":"24","author":"S Shin","year":"2005","unstructured":"Shin S, Lee Y, Kim W, Ko H, Choi H, Kim K . Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 2005; 24: 3532\u20133542.","journal-title":"EMBO J"},{"key":"BFonc2014271_CR28","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/sj.cdd.4401492","volume":"11","author":"BC Baliga","year":"2004","unstructured":"Baliga BC, Read SH, Kumar S . The biochemical mechanism of caspase-2 activation. Cell Death Differ 2004; 11: 1234\u20131241.","journal-title":"Cell Death Differ"},{"key":"BFonc2014271_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1095432","volume":"304","author":"A Tinel","year":"2004","unstructured":"Tinel A, Tschopp J . The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304: 843\u2013846.","journal-title":"Science"},{"key":"BFonc2014271_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1042\/BJ20111588","volume":"444","author":"EM Ribe","year":"2012","unstructured":"Ribe EM, Jean YY, Goldstein RL, Manzl C, Stefanis L, Villunger A et al. Neuronal caspase 2 activity and function requires RAIDD, but not PIDD. Biochem J 2012; 444: 591\u2013599.","journal-title":"Biochem J"},{"key":"BFonc2014271_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1083\/jcb.200811105","volume":"185","author":"C Manzl","year":"2009","unstructured":"Manzl C, Krumschnabel G, Bock F, Sohm B, Labi V, Baumgartner F et al. Caspase-2 activation in the absence of PIDDosome formation. J Cell Biol 2009; 185: 291\u2013303.","journal-title":"J Cell Biol"},{"key":"BFonc2014271_CR32","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.molcel.2009.07.023","volume":"35","author":"L Bouchier-Hayes","year":"2009","unstructured":"Bouchier-Hayes L, Oberst A, McStay GP, Connell S, Tait SW, Dillon CP et al. Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol Cell 2009; 35: 830\u2013840.","journal-title":"Mol Cell"},{"key":"BFonc2014271_CR33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.devcel.2009.04.005","volume":"16","author":"LK Nutt","year":"2009","unstructured":"Nutt LK, Buchakjian MR, Gan E, Darbandi R, Yoon SY, Wu JQ et al. Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2. Dev Cell 2009; 16: 856\u2013866.","journal-title":"Dev Cell"},{"key":"BFonc2014271_CR34","doi-asserted-by":"publisher","first-page":"31378","DOI":"10.1074\/jbc.M803384200","volume":"283","author":"LM Knowles","year":"2008","unstructured":"Knowles LM, Yang C, Osterman A, Smith JW . Inhibition of fatty-acid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4. J Biol Chem 2008; 283: 31378\u201331384.","journal-title":"J Biol Chem"},{"key":"BFonc2014271_CR35","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/JNEUROSCI.3292-06.2006","volume":"26","author":"C Malagelada","year":"2006","unstructured":"Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA . RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci 2006; 26: 9996\u201310005.","journal-title":"J Neurosci"},{"key":"BFonc2014271_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nm.2157","volume":"16","author":"T Yoshida","year":"2010","unstructured":"Yoshida T, Mett I, Bhunia AK, Bowman J, Perez M, Zhang L et al. Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med 2010; 16: 767\u2013773.","journal-title":"Nat Med"},{"key":"BFonc2014271_CR37","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1128\/MCB.25.14.5834-5845.2005","volume":"25","author":"A Sofer","year":"2005","unstructured":"Sofer A, Lei K, Johannessen CM, Ellisen LW . Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 2005; 25: 5834\u20135845.","journal-title":"Mol Cell Biol"},{"key":"BFonc2014271_CR38","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1128\/MCB.22.7.2283-2293.2002","volume":"22","author":"T Shoshani","year":"2002","unstructured":"Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002; 22: 2283\u20132293.","journal-title":"Mol Cell Biol"},{"key":"BFonc2014271_CR39","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1038\/onc.2011.102","volume":"30","author":"HO Jin","year":"2011","unstructured":"Jin HO, Seo SK, Kim YS, Woo SH, Lee KH, Yi JY et al. TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1. Oncogene 2011; 30: 3792\u20133801.","journal-title":"Oncogene"},{"key":"BFonc2014271_CR40","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev 2004; 18: 2893\u20132904.","journal-title":"Genes Dev"},{"key":"BFonc2014271_CR41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1101\/gad.1617608","volume":"22","author":"MP DeYoung","year":"2008","unstructured":"DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW . Hypoxia regulates TSC1\/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008; 22: 239\u2013251.","journal-title":"Genes Dev"},{"key":"BFonc2014271_CR42","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.3390\/ijms14047742","volume":"14","author":"CE Pyragius","year":"2013","unstructured":"Pyragius CE, Fuller M, Ricciardelli C, Oehler MK . Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer. Int J Mol Sci 2013; 14: 7742\u20137756.","journal-title":"Int J Mol Sci"},{"key":"BFonc2014271_CR43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3747\/co.v17i5.668","volume":"17","author":"M Tania","year":"2010","unstructured":"Tania M, Khan MA, Song Y . Association of lipid metabolism with ovarian cancer. Curr Oncol 2010; 17: 6\u201311.","journal-title":"Curr Oncol"},{"key":"BFonc2014271_CR44","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.1158\/0008-5472.CAN-05-3197","volume":"66","author":"S Bandyopadhyay","year":"2006","unstructured":"Bandyopadhyay S, Zhan R, Wang Y, Pai SK, Hirota S, Hosobe S et al. Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res 2006; 66: 5934\u20135940.","journal-title":"Cancer Res"},{"key":"BFonc2014271_CR45","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.biopha.2007.08.020","volume":"61","author":"TS Ho","year":"2007","unstructured":"Ho TS, Ho YP, Wong WY, Chi-Ming CL, Wong YS, Eng-Choon OV . Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells. Biomed Pharmacother 2007; 61: 578\u2013587.","journal-title":"Biomed Pharmacother"},{"key":"BFonc2014271_CR46","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1097-2765(02)00706-2","volume":"10","author":"LW Ellisen","year":"2002","unstructured":"Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002; 10: 995\u20131005.","journal-title":"Mol Cell"},{"key":"BFonc2014271_CR47","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 2008; 8: 224\u2013236.","journal-title":"Cell Metab"},{"key":"BFonc2014271_CR48","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1038\/emboj.2010.191","volume":"29","author":"CS Yang","year":"2010","unstructured":"Yang CS, Thomenius MJ, Gan EC, Tang W, Freel CD, Merritt TJ et al. Metabolic regulation of Drosophila apoptosis through inhibitory phosphorylation of Dronc. EMBO J 2010; 29: 3196\u20133207.","journal-title":"EMBO J"},{"key":"BFonc2014271_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1083\/jcb.201111141","volume":"197","author":"NJ Huang","year":"2012","unstructured":"Huang NJ, Zhang L, Tang W, Chen C, Yang CS, Kornbluth S . The Trim39 ubiquitin ligase inhibits APC\/CCdh1-mediated degradation of the Bax activator MOAP-1. J Cell Biol 2012; 197: 361\u2013367.","journal-title":"J Cell Biol"},{"key":"BFonc2014271_CR50","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1158\/1535-7163.MCT-07-2299","volume":"7","author":"M Upreti","year":"2008","unstructured":"Upreti M, Chu R, Galitovskaya E, Smart SK, Chambers TC . Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine. Mol Cancer Ther 2008; 7: 2224\u20132232.","journal-title":"Mol Cancer Ther"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014271","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:09:18Z","timestamp":1647893358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,25]]},"references-count":50,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2015,6,18]]}},"alternative-id":["BFonc2014271"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.271","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,25]]},"assertion":[{"value":"13 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}